LumiQuick Diagnostics Showcases Rapid Tests Across Multiple Clinical Applications
Posted on 18 Nov 2026
LumiQuick Diagnostics (Santa Clara, CA, USA) is showcasing its portfolio of rapid diagnostic tests and immunoassay solutions at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. Exhibiting in Hall 3, Stand D25-4, the company is highlighting its capabilities across infectious disease testing, drugs-of-abuse screening, cardiac and tumor markers, fertility testing, and consumer self-testing. With more than two decades of experience in in vitro diagnostics (IVD), LumiQuick provides diagnostic products and manufacturing services to healthcare providers, laboratories, and distributors worldwide.
Among the company's key offerings is its QuickProfile rapid-test portfolio, designed for point-of-care and laboratory applications. The infectious disease range includes assays for malaria, dengue, Zika, chikungunya, influenza A/B, H. pylori, adenovirus, rotavirus, HIV, and syphilis. The portfolio also encompasses tests for cardiac markers, tumor markers, fertility hormones, and vitamin D, supporting a broad range of clinical diagnostic applications.
LumiQuick also offers an extensive drugs-of-abuse (DOA) testing portfolio, including single-test strips, single-drug cards, multi-drug panels, and multi-panel cups. The QuickProfile DOA range covers substances such as methamphetamine, cocaine, opiates, THC, fentanyl, and synthetic cannabinoids. These products provide different testing formats for drug screening applications in healthcare and laboratory settings.
The company's broader portfolio includes the Aoxre OxisResearch range, which provides assays for measuring oxidative stress biomarkers, antioxidants, DNA damage, and related indicators. These products support research into oxidative, nitrosative, and inflammatory processes associated with various medical conditions. In addition to its diagnostic products, LumiQuick offers original equipment manufacturing (OEM) and original design manufacturing (ODM) services, supporting partners in developing and marketing diagnostic solutions under their own brands.